8-19951924-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000237.3(LPL):​c.405G>A​(p.Val135Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0342 in 1,614,046 control chromosomes in the GnomAD database, including 1,345 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 347 hom., cov: 32)
Exomes 𝑓: 0.032 ( 998 hom. )

Consequence

LPL
NM_000237.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.537
Variant links:
Genes affected
LPL (HGNC:6677): (lipoprotein lipase) LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 8-19951924-G-A is Benign according to our data. Variant chr8-19951924-G-A is described in ClinVar as [Benign]. Clinvar id is 362407.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-19951924-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.537 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LPLNM_000237.3 linkuse as main transcriptc.405G>A p.Val135Val synonymous_variant 3/10 ENST00000650287.1 NP_000228.1 P06858A0A1B1RVA9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LPLENST00000650287.1 linkuse as main transcriptc.405G>A p.Val135Val synonymous_variant 3/10 NM_000237.3 ENSP00000497642.1 P06858
LPLENST00000520959.5 linkuse as main transcriptc.177G>A p.Val59Val synonymous_variant 3/54 ENSP00000428496.1 E7EW14
LPLENST00000524029.5 linkuse as main transcriptc.*16G>A downstream_gene_variant 4 ENSP00000428237.1 E5RJI0

Frequencies

GnomAD3 genomes
AF:
0.0546
AC:
8298
AN:
152076
Hom.:
346
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0420
Gnomad ASJ
AF:
0.0657
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00932
Gnomad FIN
AF:
0.0347
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0331
Gnomad OTH
AF:
0.0445
GnomAD3 exomes
AF:
0.0332
AC:
8353
AN:
251430
Hom.:
225
AF XY:
0.0313
AC XY:
4247
AN XY:
135890
show subpopulations
Gnomad AFR exome
AF:
0.115
Gnomad AMR exome
AF:
0.0252
Gnomad ASJ exome
AF:
0.0661
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0103
Gnomad FIN exome
AF:
0.0290
Gnomad NFE exome
AF:
0.0334
Gnomad OTH exome
AF:
0.0334
GnomAD4 exome
AF:
0.0320
AC:
46818
AN:
1461852
Hom.:
998
Cov.:
31
AF XY:
0.0316
AC XY:
22997
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.116
Gnomad4 AMR exome
AF:
0.0262
Gnomad4 ASJ exome
AF:
0.0631
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0107
Gnomad4 FIN exome
AF:
0.0266
Gnomad4 NFE exome
AF:
0.0317
Gnomad4 OTH exome
AF:
0.0367
GnomAD4 genome
AF:
0.0546
AC:
8317
AN:
152194
Hom.:
347
Cov.:
32
AF XY:
0.0535
AC XY:
3977
AN XY:
74390
show subpopulations
Gnomad4 AFR
AF:
0.111
Gnomad4 AMR
AF:
0.0420
Gnomad4 ASJ
AF:
0.0657
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00912
Gnomad4 FIN
AF:
0.0347
Gnomad4 NFE
AF:
0.0331
Gnomad4 OTH
AF:
0.0441
Alfa
AF:
0.0418
Hom.:
219
Bravo
AF:
0.0577
Asia WGS
AF:
0.0110
AC:
38
AN:
3478
EpiCase
AF:
0.0388
EpiControl
AF:
0.0406

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 07, 2017Variant summary: The LPL c.405G>A (p.Val135Val) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect ESE site of SF2/ASF. This variant was found in 4195/121380 control chromosomes (117 homozygotes) from ExAC, predominantly observed in the African subpopulation at a frequency of 0.116997 (1217/10402). This frequency is about 35 times the estimated maximal expected allele frequency of a pathogenic LPL variant (0.0033541), thus this is a benign polymorphism found primarily in the populations of African origin. This variant was also not associated with Type 2 diabetes or lowered HDL-C levels in a case-control study from India (Ayyappa_2017). One clinical laboratory (via ClinVar) has classified this variant as likely benign. Taken together, this variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 19, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Hyperlipoproteinemia, type I Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Dystrophin deficiency Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 03, 2019This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
6.0
DANN
Benign
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1121923; hg19: chr8-19809435; COSMIC: COSV60932154; COSMIC: COSV60932154; API